The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
Abstract Sodium–glucose cotransporter 2 inhibitors (SGLT2i) exhibit renoprotective effect in patients with chronic kidney disease (CKD) and reduce serum uric acid (UA) in patients with diabetes mellitus. However, it is not clarified whether SGLT2i reduce serum UA levels in patients with advanced CKD...
Main Authors: | Yukimasa Iwata, Shoki Notsu, Yushi Kawamura, Waka Mitani, Shinjiro Tamai, Madoka Morimoto, Masafumi Yamato |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-32072-y |
Similar Items
-
Association between urinary uric acid excretion and kidney outcome in patients with CKD
by: Yuta Asahina, et al.
Published: (2024-03-01) -
Uric acid transporters BCRP and MRP4 involved in chickens uric acid excretion
by: Xuedong Ding, et al.
Published: (2019-05-01) -
Urine alkalization facilitates uric acid excretion
by: Seyama Issei, et al.
Published: (2010-10-01) -
Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels.
by: Kyoko Fujita, et al.
Published: (2019-01-01) -
Carnosine reduces serum uric acid in hyperuricemia rats via restoring hepatorenal dysfunction and enhancing uric acid excretion by inhibiting inflammation
by: Ming Chen, et al.
Published: (2023-11-01)